GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenas BioPharma Inc (NAS:ZBIO) » Definitions » Scaled Net Operating Assets

ZBIO (Zenas BioPharma) Scaled Net Operating Assets : -0.13 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Zenas BioPharma Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Zenas BioPharma's operating assets for the quarter that ended in Sep. 2024 was $16.63 Mil. Zenas BioPharma's operating liabilities for the quarter that ended in Sep. 2024 was $43.61 Mil. Zenas BioPharma's Total Assets for the quarter that ended in Jun. 2024 was $199.95 Mil. Therefore, Zenas BioPharma's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was -0.13.

Zenas BioPharma Scaled Net Operating Assets Historical Data

The historical data trend for Zenas BioPharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenas BioPharma Scaled Net Operating Assets Chart

Zenas BioPharma Annual Data
Trend Dec22 Dec23
Scaled Net Operating Assets
-3.46 -3.51

Zenas BioPharma Quarterly Data
Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only - -3.12 -3.93 -9.63 -0.14

Competitive Comparison of Zenas BioPharma's Scaled Net Operating Assets

For the Biotechnology subindustry, Zenas BioPharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zenas BioPharma's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zenas BioPharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Zenas BioPharma's Scaled Net Operating Assets falls into.


Zenas BioPharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Zenas BioPharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(11.323-272.788)/74.579
=-3.51

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=68.18 - 56.857
=11.323

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=293.901 - 20.557 - 0.556
=272.788

Zenas BioPharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(16.633-43.613)/199.952
=-0.13

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=403.432 - 386.799
=16.633

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=43.997 - 0 - 0.384
=43.613

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenas BioPharma Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Zenas BioPharma's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Zenas BioPharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenas BioPharma Inc (NAS:ZBIO) » Definitions » Scaled Net Operating Assets
Comparable Companies
Traded in Other Exchanges
N/A
Address
1000 Winter Street, North Building, Suite 1200, Waltham, MA, USA, 02451
Website
https://www.zenasbio.com
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.